---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-073391"
form_type: "8-K"
ticker: "IRWD"
cik: "0001446847"
company_name: "IRONWOOD PHARMACEUTICALS INC"
filed_at: "2024-06-20T23:59:59+00:00"
generated_at: "2026-06-01T03:21:35.626959+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ironwood repays $200M convertible notes at maturity using cash and revolver; CFO adds COO role

## Summary
- Repaid $200M 0.75% Convertible Senior Notes due 2024 on June 17 using $50M cash and $150M from $500M revolver.
- Outstanding balance on $500M revolver increased to $425M following the $150M draw.
- Expects ~$100M cash and cash equivalents as of June 30, 2024 (preliminary estimate).
- Sravan K. Emany, current CFO, also appointed Chief Operating Officer effective immediately.
- Emany has been CFO since Dec 2021; no family relationships or transactions disclosed.

## SEC filing metadata
- accession: 0001104659-24-073391
- form_type: 8-K
- ticker: IRWD
- cik: 0001446847
- company_name: IRONWOOD PHARMACEUTICALS INC
- filed_at: 2024-06-20T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446847/000110465924073391/0001104659-24-073391-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446847/000110465924073391/tm2417654d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-073391
- JSON: https://secwatch.observer/filing/0001104659-24-073391.json
- Plain text: https://secwatch.observer/filing/0001104659-24-073391.txt

## Key facts
- Executive change
  Sravan K. Emany was appointed as Senior Vice President, Chief Operating Officer and Chief Financial Officer at IRONWOOD PHARMACEUTICALS INC.
  - Action: appointed
  - Role: Senior Vice President, Chief Operating Officer and Chief Financial Officer
  source text: On June 18, 2024, the Board of Directors of Ironwood Pharmaceuticals, Inc. (the “Company”) appointed Sravan K. Emany, age 46, the Company’s Senior Vice President, Chief Financial Officer, to the position of Senior Vice President, Chief Operating Officer and Chief Financial Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446847/000110465924073391/0001104659-24-073391-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.